ERBB2 and breast carcinoma: Upon ultrasound-stimulated delivery to SkBr3 (breast cancer cells over-expressing HER2) in vitro, cells expressed GFP (while there was no expression when microcarriers were delivered without ultrasound) (Figure 3D).